Comment for Type of Reporting Person:   The reported securities are owned directly by U.S. Venture Partners XII, L.P. ("USVP XII"). Presidio Management Group XII, L.L.C. ("PMG XII") is the general partner of each of the USVP XII Funds (as defined below) and may be deemed to have sole voting and dispositive power over the reported securities held by the USVP XII Funds. Dr. Jonathan Root, a member of the Issuer's board of directors, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 26,592,908 shares of Common Stock outstanding as of November 3, 2025 as reported by the Issuer in its Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the Commission) on November 6, 2025 ("the Form 10-Q").

Comment for Type of Reporting Person:   Consists of (i) 4,305,806 shares of Common Stock held directly by USVP XII, (ii) 218,524 shares of Common Stock held directly by U.S. Venture Partners XII-A, L.P. ("USVP XII-A", and together with USVP XII, the "USVP XII Funds"), and (iii) 1,117,743 shares of Common Stock held directly by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A"). PMG XII is the general partner of each of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI", and together with USVP XII and USVP XII-A, USVP SIF, USVP SFI-A, and PMG XII, the "U.S. Venture Partners") is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, a member of the Issuer's board of directors, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII, who may be deemed to share voting and dispositive power over the shares held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 26,592,908 shares of Common Stock outstanding as of November 3, 2025 as reported by the Issuer in its Form 10-Q.

Comment for Type of Reporting Person:   Consists of (i) 4,305,806 shares of Common Stock held directly by USVP XII, (ii) 218,524 shares of Common Stock held directly by USVP XII-A, and (iii) 1,117,743 shares of Common Stock held directly by USVP SFI, on its own behalf and as nominee for USVP SFI-A. PMG XII is the general partner of each of USVP XII and USVP XII-A. PMG SFI is the general partner of USVP SFI and USVP SFI-A. Dr. Jonathan Root, a member of the Issuer's board of directors, Steven Krausz, Richard Lewis and Dafina Toncheva are the managing members of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by U.S. Venture Partners. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by U.S. Venture Partners. Each such persons and entities disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein. The amount beneficially owned by each Reporting Person is determined based on 26,592,908 shares of Common Stock outstanding as of November 3, 2025 as reported by the Issuer in its Form 10-Q.